细菌凝结剂市场规模、份额、成长分析，按类型、来源、应用、最终用户、地区 - 产业预测，2025-2032

2023年凝结细菌的全球市场规模为9183万美元，从2024年的9927万美元增长到2032年的1.851亿美元，预计在预测期内（2025-2032年）复合年增长率为8.1。

由于健康意识的提高和对机能性食品需求的激增，凝结乳桿菌（一种类似于乳酸菌的有益细菌）的全球市场正在显着增长。凝结芽孢桿菌以其治疗用途而闻名，已被证明可以治疗 IBS、发炎性肠道疾病(IBD) 和呼吸道感染疾病等疾病，以及许多类型的腹泻，包括由轮状病毒等感染疾病引起的腹泻。此外，它还具有增强免疫系统的作用，并具有其他健康益处。然而，由于消费者对其有效性缺乏广泛认识，其市场潜力在一定程度上受到限制。然而，新兴经济体不断扩大的研发和对凝固剂产品日益增长的兴趣为未来的成长机会带来了希望。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 客户和购买标准分析

凝结剂市场规模：依类型

• 市场概况
• 类型1
• 2型
• 类型3

凝结剂市场规模：依来源分类

• 市场概况
• 自然资源
• 植物
• 动物
• 临床资讯来源
• 其他的

凝结剂市场规模：依应用分类

• 市场概况
• 不含乳製品
• 乳製品
• 粮食
• 药品
• 婴儿营养
• 其他的

凝结剂市场规模：依最终用户划分

• 市场概况
• 饮食
• 化妆品产业
• 营养补充品製造商
• 药品製造商
• 畜牧业和护理
• 其他的

凝结剂市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• Kerry Group plc（Ireland）
• Sabinsa Corporation（United States）
• Mitsubishi Chemical Foods Corporation（Japan）
• Sanzyme Biologics（India）
• Unique Biotech Limited（India）
• Syngen Biotech Co., Ltd.（China）
• Synbiotech（Taiwan）
• Ganeden（United States）
• Biosearch Life（Spain）
• ADM Protexin Limited（United Kingdom）
• Bactolac Pharmaceutical, Inc.（United States）
• Nutraceutix, Inc.（United States）
• Thorne Research Inc.（United States）
• Vitamer Labs Inc.（United States）
• Nutralliance Inc.（United States）
• **Microbax（India）
• Zytex Biotech Pvt. Ltd.（India）
• Bioflex（India）
• Fengchen Group Co., Ltd.（China）

结论和建议

Global Bacillus Coagulans Market size was valued at USD 91.83 million in 2023 and is poised to grow from USD 99.27 million in 2024 to USD 185.1 million by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global market for Bacillus coagulans, a beneficial bacterium akin to lactobacillus, is witnessing significant growth driven by heightened health awareness and a surge in demand for functional foods. Known for its therapeutic applications, Bacillus coagulans is effective in treating various types of diarrhea, including those caused by infections like rotavirus, as well as conditions such as IBS, inflammatory bowel diseases (IBD), and respiratory infections. Furthermore, its role in bolstering the immune system presents additional health benefits. However, the market's potential is somewhat hindered by widespread consumer unawareness regarding its effectiveness. Nonetheless, the expansion of research and development and increased interest in Bacillus coagulans products in emerging economies presents promising opportunities for future growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bacillus Coagulans market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bacillus Coagulans Market Segmental Analysis

Global Bacillus Coagulans Market is segmented by Type, Sources, Application, End-Users and region. Based on Type, the market is segmented into Type1, Type2 and Type3. Based on Sources, the market is segmented into Natural Source, Plants, Animals, Clinical Sources and Others. Based on Application, the market is segmented into Non-Dairy, Dairy, Cereal, Drugs, Infant Nutrition and Others. Based on End-Users, the market is segmented into Food and Beverages, Cosmeceutical Industries, Nutraceutical Manufacturers, Pharmaceutical Manufacturers, Animal Husbandry and Care and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bacillus Coagulans Market

The global Bacillus Coagulans market is primarily driven by its significant benefits in addressing acne and various skin conditions, leading to an increased demand within the cosmetics industry. Cosmetic manufacturers are formulating innovative products infused with Bacillus Coagulans, highlighting its anti-aging properties across a wide range of items, including face masks, lotions, scrubs, gels, creams, and cleansers. Additionally, there is a growing trend towards the incorporation of Bacillus Coagulans as a cosmeceutical component in diverse cosmetic products, such as creams and powders. Its effectiveness in managing conditions like atopic dermatitis and eczema further elevates its use in moisturizers and anti-acne treatments, solidifying its role as a crucial ingredient in personal care formulations.

Restraints in the Global Bacillus Coagulans Market

The global Bacillus coagulans market faces certain constraints primarily related to safety concerns and side effects associated with its use. While generally considered safe, indiscriminate dosing can lead to gastrointestinal issues such as gas and bloating. The lack of familiarity with Bacillus coagulans in the human digestive system raises ongoing debates regarding its potential risks and adverse effects. Additionally, some identified strains are not suitable for probiotic applications, and the existing research on these probiotics remains limited. Furthermore, there is apprehension that Bacillus coagulans spores could potentially escape the digestive tract and affect other organs, posing risks for immunocompromised individuals or those with catheters, as this could lead to bacterial infections.

Market Trends of the Global Bacillus Coagulans Market

The Global Bacillus Coagulans market is witnessing significant growth, driven by a rising consumer shift towards health-conscious dietary choices, particularly in dairy-free and vegan segments. This trend is largely fueled by increasing lactose intolerance, milk protein allergies, and a burgeoning vegan population, leading to a heightened demand for non-dairy probiotics. Bacillus coagulans has emerged as a preferred ingredient due to its recognized safety by regulatory bodies like the FDA and EFSA, making its way into functional foods and supplements. Furthermore, its impressive stability during processing enhances its appeal, while affordability positions it as a viable alternative to potentially harmful chemicals in the food industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Customer & Buying Criteria Analysis

Global Bacillus Coagulans Market Size by Type & CAGR (2025-2032)

• Market Overview
• Type1
• Type2
• Type3

Global Bacillus Coagulans Market Size by Sources & CAGR (2025-2032)

• Market Overview
• Natural Source
• Plants
• Animals
• Clinical Sources
• Others

Global Bacillus Coagulans Market Size by Application & CAGR (2025-2032)

• Market Overview
• Non-Dairy
• Dairy
• Cereal
• Drugs
• Infant Nutrition
• Others

Global Bacillus Coagulans Market Size by End-Users & CAGR (2025-2032)

• Market Overview
• Food and Beverages
• Cosmeceutical Industries
• Nutraceutical Manufacturers
• Pharmaceutical Manufacturers
• Animal Husbandry and Care
• Others

Global Bacillus Coagulans Market Size & CAGR (2025-2032)

• North America (Type, Sources, Application, End-Users)
  • US
  • Canada
• Europe (Type, Sources, Application, End-Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Sources, Application, End-Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Sources, Application, End-Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Sources, Application, End-Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Kerry Group plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sabinsa Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Chemical Foods Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanzyme Biologics (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Unique Biotech Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngen Biotech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbiotech (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ganeden (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosearch Life (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADM Protexin Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bactolac Pharmaceutical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutraceutix, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thorne Research Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitamer Labs Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutralliance Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• **Microbax (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zytex Biotech Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioflex (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fengchen Group Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations